RAFAEL HOLDINGS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- RAFAEL HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2022-07-31 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2022-04-30 was $0.00, a 100.00% decline year-over-year.
- RAFAEL HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2022-01-31 was $0.00.
- RAFAEL HOLDINGS, INC. stock issued during period, value, new issues for the quarter ending 2021-10-31 was $99.17M.
- RAFAEL HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2025 was $24.91M.
- RAFAEL HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2022 was $99.17M, a 1066.57% increase from fiscal 2021.
- RAFAEL HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2021 was $8.50M.
- RAFAEL HOLDINGS, INC. stock issued during period, value, new issues for fiscal 2017 was $10.00M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-07-31 | $24.91M 10-K · filed 2025-10-29 | |
| 2022-07-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-30 | $99.17M 10-K · filed 2023-10-30 |
| 2022-04-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-06-13 | $101.42M derived: sum of 4 quarters · filed 2023-06-13 |
| 2022-01-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | $107.67M derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-10-31 | $99.17M 10-Q · filed 2022-12-13 | |
| 2021-07-31 | $2.25M derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-18 | $8.50M 10-K · filed 2021-10-18 |
| 2021-04-30 | $6.25M 10-Q · filed 2021-06-14 | |
| 2017-07-31 | $10.00M 10-K · filed 2018-10-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |